does glp 1 help with crohn's disease SAFETY AND CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL PATIENTS Frontiers | GLP-1 and GLP-2

The most important limitation with regard to nonsurgical treatment of GLP-1-based weight loss patients is the current lack of clinical data specific to these individuals

Keep up with your regular scale and clean appointments

Theres also this recent headline: Which is a touchy subject and I dont want to settle the European regulators investigation (notoriously not overly sensitive about things), but Id venture to say that the psychological impact of obesity and the psychiatric side effects associated with changing body type including dysmorphia and eating disorders probably indicate that this is not a side effect of the drug but rather a side effect of the primary effect of the drug, in a small subset of patients

However, it is crucial to understand that microdosing GLP-1 is not an evidence-based practice and lacks formal clinical trial data supporting its efficacy or safety

Provider-led care for women Personalized to perimenopause and menopause Complete a short intake and a licensed provider will review your case and discuss your options